Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Appointment of Joint Corporate Broker

20th Mar 2025 07:00

RNS Number : 3833B
BioPharma Credit PLC
20 March 2025
 

20 March 2025

 

BioPharma Credit plc

 

(the "Company")

 

APPOINTMENT OF JOINT CORPORATE BROKER

 

BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor, is pleased to announce the appointment of Investec Bank plc as joint corporate broker to work alongside JPMorgan Cazenove, the Company's existing corporate broker, with effect from 10 March 2025.

 

The contact information for the Company's joint corporate brokers is as follows:

 

JPMorgan Cazenove

Investec Bank plc

William Simmonds [email protected]

David Yovichic

[email protected]

Mary-Jane Clarke

[email protected]

Lucy Lewis

[email protected]

 

 

Enquiries:

BioPharma Credit plc

via MUFG Corporate Governance Limited

Company Secretary

+44 (0) 333 300 1932

Burson Buchanan

Mark Court / Jamie Hooper / Henry Wilson / Samuel Adams

+44 (0)20 7466 5000

[email protected]

 

Notes to Editors:

 

BioPharma Credit PLC is London's only specialist debt investor to the life sciences industry and joined the LSE in March 2017. BioPharma Credit PLC seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. BioPharma Credit PLC seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

 

 

LEI: 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPGZGMFGLVGKZZ

Related Shares:

Biopharma Cred.
FTSE 100 Latest
Value8,474.74
Change-133.74